91 related articles for article (PubMed ID: 20369480)
1. [Expression of beta-catenin and estrogen receptor in desmoid-type fibromatosis].
Zhang HY; Ke Q; Zhang Z; Zhang R; Fu J; Chen HJ; Wei B; Bu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):101-5. PubMed ID: 20369480
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases.
Thway K; Gibson S; Ramsay A; Sebire NJ
Pediatr Dev Pathol; 2009; 12(4):292-6. PubMed ID: 18939887
[TBL] [Abstract][Full Text] [Related]
3. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
4. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Coffin CM; Hornick JL; Zhou H; Fletcher CD
Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis.
Miller DV; Wang H; Wang H; Fealey ME; Tazelaar HD
Pediatr Dev Pathol; 2008; 11(4):291-4. PubMed ID: 18078366
[TBL] [Abstract][Full Text] [Related]
6. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC
Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468
[TBL] [Abstract][Full Text] [Related]
8. Infantile digital fibroma/fibromatosis: a clinicopathologic and immunohistochemical study of 69 tumors from 57 patients with long-term follow-up.
Laskin WB; Miettinen M; Fetsch JF
Am J Surg Pathol; 2009 Jan; 33(1):1-13. PubMed ID: 18830128
[TBL] [Abstract][Full Text] [Related]
9. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the usefulness of nuclear beta-catenin in the diagnosis of desmoid-type fibromatosis among commonly used anti-beta-catenin antibodies.
Yamada Y; Hirata M; Sakamoto A; Noguchi T; Ito K; Nishida Y; Matsuda S; Haga H
Pathol Int; 2021 Jun; 71(6):392-399. PubMed ID: 33788979
[TBL] [Abstract][Full Text] [Related]
11. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects, classification and prognosis of 7 cases of pediatric fibromatosis].
Ure BM; Holschneider AM; Gharib M; Halsband H; Hinselmann D
Z Kinderchir; 1988 Feb; 43(1):27-30. PubMed ID: 3376585
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.
Mignemi NA; Itani DM; Fasig JH; Keedy VL; Hande KR; Whited BW; Homlar KC; Correa H; Coffin CM; Black JO; Yi Y; Halpern JL; Holt GE; Schwartz HS; Schoenecker JG; Cates JM
Cancer Sci; 2012 Dec; 103(12):2173-80. PubMed ID: 23035734
[TBL] [Abstract][Full Text] [Related]
14. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
[TBL] [Abstract][Full Text] [Related]
15. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
16. Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis.
Gebert C; Hardes J; Kersting C; August C; Supper H; Winkelmann W; Buerger H; Gosheger G
Histopathology; 2007 Mar; 50(4):491-7. PubMed ID: 17448025
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of beta-catenin in solitary fibrous tumors.
Rakheja D; Molberg KH; Roberts CA; Jaiswal VR
Arch Pathol Lab Med; 2005 Jun; 129(6):776-9. PubMed ID: 15913427
[TBL] [Abstract][Full Text] [Related]
18. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
19. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors.
Fritsch MK; Schneider DT; Schuster AE; Murdoch FE; Perlman EJ
Pediatr Dev Pathol; 2006; 9(2):115-31. PubMed ID: 16822086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
